Håvard Sletta

Title: Håvard Sletta: Innovator in Polyketide Research

Introduction

Håvard Sletta is a prominent inventor based in Trondheim, Norway. He has made significant contributions to the field of biotechnology, particularly in the manipulation and utility of nucleic acid molecules. With a total of three patents to his name, Sletta's work focuses on the synthesis of polyketide-based compounds, which have important applications in pharmaceuticals.

Latest Patents

Sletta's latest patents include the "NRPS-PKS gene cluster and its manipulation and utility." This invention provides a nucleic acid molecule that encompasses various nucleotide sequences, which can be modified to enhance the synthesis of polyketide macrolactam molecules. Another notable patent is related to "Genes encoding a nystatin polyketide synthase and their manipulation and utility." This invention outlines a nucleic acid molecule that facilitates the biosynthesis of nystatin and its derivatives, showcasing Sletta's innovative approach to genetic engineering.

Career Highlights

Throughout his career, Håvard Sletta has worked with notable companies such as Sinvent AS and Sintef TTO AS. His experience in these organizations has allowed him to develop and refine his expertise in biotechnology and patent development. His contributions have been instrumental in advancing research in polyketide synthesis.

Collaborations

Sletta has collaborated with esteemed colleagues, including Sergey Zotchev and Espen Fjærvik. These partnerships have fostered a collaborative environment that enhances innovation and research in their respective fields.

Conclusion

Håvard Sletta's work in biotechnology and his innovative patents have made a significant impact on the field of polyketide research. His contributions continue to influence the development of new therapeutic compounds.